New hope for advanced colon cancer patients after standard treatments fail
NCT ID NCT06199232
Summary
This study is testing a personalized combination treatment for people with advanced colorectal cancer that has spread to the liver and is no longer responding to standard treatments. The treatment combines a targeted drug (chosen based on a blood test of the tumor's genetics), an immunotherapy drug, and a specialized form of chemotherapy delivered directly to the liver. The goal is to see if this approach can better control the cancer and extend life for patients who have run out of other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Univerisity Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Conditions
Explore the condition pages connected to this study.